関与物質
| 役割 | 名称 | HCID | 仕込み量 |
|---|
| 反応物 | Cesium bicarbonate | HCID 2734983 | — |
| 反応物 | Methyl 5-hydroxypyridine-2-carboxylate | HCID 4715126 | — |
| 反応物 | 2,3-Dihydro-1,2-oxazole | HCID 19350417 | — |
| 反応物 | 3-Bromo-5-(4-(trifluoromethoxy)phenyl)-4,5-dihydroisoxazole | HCID 66818049 | — |
| 溶媒 | Dimethylformamide | HCID 6228 | — |
| 生成物 | 3-(Pyridin-3-yloxy)-4,5-dihydroisoxazole | HCID 66818532 | — |
反応手順
3-(pyridin-3-yloxy)-4,5-dihydroisoxazole I-96a and I-96b were prepared in 1 step from racemic compound I-14 and 5-hydroxypicolinic acid methyl ester according to the following procedure: 3-bromo-5-(4-(trifluoromethoxy)phenyl)-4,5-dihydroisoxazole (1.0 equiv), 5-hydroxypicolinic acid methyl ester (1.2 equiv), and cesium hydrogencarbonate (1.50 equiv) are suspended in N,N-dimethylforamide (0.32 M with respect to dihydroisoxazole. The mixture is then degassed with argon after which it is heated to 130° C. for 4 h after which point there is only desired product and corresponding acid visible by LC/MS. The reaction is allowed to cool to room temperature and quenched by pouring into a solution of ammonium chloride in water (30% by weight, 0.08 M with respect to dihydroisoxazole). The aqueous phase is extracted with ethyl acetate (2×), dried over sodium sulfate, filtered and concentrated to product a brown solid which could be recystallized from absolute ethanol to provide racemic 3-(pyridin-3-yloxy)-4,5-dihydroisoxazole I-96 that was isolated by filtration as a white solid (25% yield). These compounds can be separated using chiral HPLC methods known in the art. For example, see chiral HPLC Method disclosed herein. [M+H]+=383.8 m/z. Activity: A
情報源と証拠
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|
| 特許番号 | US09149465B2 |
|---|
| 出典データセット | uspto-grants-2015_10 |
|---|
| ORD ID | ord-b5b665911c20495bbf0b390b1412e278 |
|---|
| 出典メモ | uspto-grants-2015_10 |
|---|